-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...

-The Hindu If India were to relax visa restrictions and allow open immigration, Pakistan could witness the largest exodus of minorities since 1947, especially from the remote areas of Sindh, Balochistan and other disturbed areas where kidnappings, forcible conversions, marriages of minor girls, ransacking of residences, robbing of commercial establishments and religious persecution continues unabated. The state apparatus is either non-existent or a mute spectator. This opinion was voiced by an overwhelming...

-Reuters India's monsoon rains retreated to below average levels in the past week, the weather office said on Thursday, after scraping above average the previous week for the first time this season, keeping overall rainfall under par and pushing futures higher. Monsoon rains were 22 per cent below average in the week to July 18 against one per cent above average rains in the previous week, reflecting the return of a weak...

-The Hindu Every fourth girl married in rural Rajasthan and every fifth girl married in rural Bihar and Jharkhand is less than 18 years -- this despite several measures taken by the government to check child marriages in the country. Only 50 per cent deliveries are considered safe in Jharkhand and Chhattisgarh and just about 45 per cent children are fully immunised in Uttar Pradesh. The percentage of men getting married...

-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...